Application 211020
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 150MG | No | No |
| 002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211020-001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | |
| A211020-002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211020-001 | AB3 |
| A211020-002 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A211020-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A211020-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2019-01-28 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A211020-001 | AB3 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211020-002 | AB3 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A211020-001 | AB3 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211020-002 | AB3 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211020-001 | AB3 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211020-002 | AB3 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211020-001 | AB3 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211020-002 | AB3 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211020-001 | AB3 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211020-002 | AB3 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211020-001 | AB3 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211020-002 | AB3 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211020-001 | AB3 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211020-002 | AB3 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211020-001 | AB3 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211020-002 | AB3 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211020-001 | AB3 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211020-002 | AB3 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211020-001 | AB3 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211020-002 | AB3 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A211020-001 | AB3 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211020-002 | AB3 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211020-001 | AB3 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211020-002 | AB3 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211020-001 | AB3 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211020-002 | AB3 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211020-001 | AB3 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211020-002 | AB3 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A211020-001 | AB3 | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A211020-002 | AB3 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211020-001 | AB3 | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211020-002 | AB3 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A211020-001 | AB3 | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A211020-002 | AB3 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A211020-001 | AB3 | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A211020-002 | AB3 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A211020-001 | AB3 | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A211020-002 | AB3 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A211020-001 | AB3 | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A211020-002 | AB3 | 1 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | a613cfd3-1aa1-49c5-b742-b105c97d73f1 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 211020 ANDA211020 |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 136f29fa-a859-4efb-8365-1382716d6f8f | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 211020 ANDA211020 |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Rising Pharma Holdings, Inc. | e4f4d3fa-ddf6-4125-8486-8157efc095c1 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | 211020 ANDA211020 16571-863 16571-862 |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | d087222e-c5e9-4c48-b27f-e2e2944379c8 | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | 211020 ANDA211020 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | aeb506f8-97c2-409a-aac9-5a73c840e8f3 | 2024-08-12 | Boxed warning, Warnings, Adverse reactions | 211020 ANDA211020 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16571-862 | Bupropion Hydrochloride | Bupropion Hydrochloride | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-863 | Bupropion Hydrochloride | Bupropion Hydrochloride | Rising Pharma Holdings, Inc. | ANDA | Current |
| 58657-710 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-710 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-710 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-711 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-711 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-711 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-712 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-712 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-713 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-713 | Bupropion hydrochloride | Bupropion hydrochloride | Method Pharmaceuticals, LLC | ANDA | Current |
| 68788-8272 | Bupropion hydrochloride | Bupropion hydrochloride | Preferred Pharmaceuticals Inc. | ANDA | Current |
| 69844-010 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-010 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-010 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-010 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-011 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-011 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-011 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-011 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-064 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-064 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-065 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-065 | bupropion hydrochloride | extended-release | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 70377-034 | bupropion hydrochloride | bupropion hydrochloride | Biocon Pharma Inc., | ANDA | Current |
| 70377-034 | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | Biocon Pharma Inc., | ANDA | Current |
| 70377-034 | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | Biocon Pharma Inc., | ANDA | Current |
| 70377-035 | bupropion hydrochloride | bupropion hydrochloride | Biocon Pharma Inc., | ANDA | Current |
| 70377-035 | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | Biocon Pharma Inc., | ANDA | Current |
| 70377-035 | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | Biocon Pharma Inc., | ANDA | Current |